Dr. Yu is a data scientist for the Cancer Research Institute (CRI) Anna-Maria Kellen Clinical Accelerator and Venture Fund. The Clinical Accelerator is a unique academia-nonprofit-industry collaboration model that serves as an incubator that delivers multi-center, science-driven clinical trials of promising new cancer immunotherapy combinations. As CRI’s clinical program, the Clinical Accelerator enables an integrative collaboration approach designed to de-risk drug development in cancer immunotherapy through a leveraged philanthropic financial model. Dr. Yu supports the science for these trials by tracking the immuno-oncology agent pipeline and clinical trial landscape. Dr. Yu has a background in oncological drug discovery and data science after obtaining Ph.D. at Graduate School of the Icahn School of Medicine at Mount Sinai for discovering a new liver cancer target and drug scaffold with isoform selectivity.